Sugary Drink Ban + Counseling for Metabolic Health Improvement
(MHIP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine how eliminating sugary drinks at work and providing brief counseling (known as Brief Intervention) can improve employee health. Participants may encounter a ban on sugary drinks at their workplace, a brief counseling session, or both. The trial targets full-time employees who speak English, consume at least three sugary drinks a week, and are willing to undergo two fasting blood tests. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance workplace health strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this multilevel workplace intervention is safe for employees?
Research has shown that banning the sale of sugary drinks at work can reduce consumption. One study found that these bans are generally safe and accepted by employees, even among those at higher risk for health problems like heart disease and diabetes. These situations reported no major negative effects.
For the brief intervention treatment, past studies have shown that motivational counseling (a focused conversation to encourage healthier habits) is safe and effective. This method has been used in various settings to help people improve their health without causing harm. Participants usually respond well, and no significant negative effects have been reported.
Both the workplace ban on sugary drinks and the brief intervention aim to safely improve health and have been used in similar situations without major issues.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to improve metabolic health by focusing on environmental changes and personal counseling, rather than just medication or traditional diet plans. The unique approach combines a workplace sugary drink ban with brief, personalized video and phone interventions. Unlike standard treatments that might rely on medication or lengthy lifestyle programs, this trial examines how altering the workplace environment and offering concise, ongoing support can impact health outcomes. This could provide a more accessible and sustainable option for improving metabolic health.
What evidence suggests that this trial's treatments could be effective for improving metabolic health?
Research has shown that banning sugary drinks at work, one of the interventions in this trial, helps employees reduce their consumption. This reduction can lead to smaller waistlines and other health benefits. Additionally, a short session using motivational interviewing, another intervention in this trial, can help people change habits related to weight and health. This trial will test these methods both separately and together. Using these two methods together might further improve employee health. Studies suggest that this combined approach could effectively enhance health at work.13678
Who Is on the Research Team?
Elissa Epel, Ph.D
Principal Investigator
University of California, San Francisco
Laura A Schmidt, Ph.D
Principal Investigator
University of California, San Francisco
Jamey Schmidt
Principal Investigator
Sutter Health/California Pacific Medical Center Research Institute
Are You a Good Fit for This Trial?
This trial is for full-time employees at certain Sutter Health sites who drink three or more sugary drinks a week, can speak and read English, and are willing to have two fasting blood tests. Pregnant individuals cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a workplace SSB sales ban and/or brief counseling intervention
Follow-up
Participants are monitored for changes in health metrics such as lipid profile, insulin sensitivity, and BMI
What Are the Treatments Tested in This Trial?
Interventions
- Brief Intervention
- Workplace SSB sales ban
Brief Intervention is already approved in United States, European Union for the following indications:
- Alcohol misuse in HIV care
- Substance use disorder
- Alcohol misuse
- Substance use disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Sutter Health
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
California Pacific Medical Center Research Institute
Collaborator